#obesitydrugs Tech News.
1 story in the last 7 days
The latest obesitydrugs news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks obesitydrugs across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
AIThe Motley Foolabout 3 hours ago
Trump bull market may end but Eli Lilly and another stock will outperformThe S&P 500 has gained 23% since Trump's inauguration and its Shiller CAPE ratio remains at historic highs. Inflation and high valuations suggest the bull market may end soon. Eli Lilly, up 1.56%, leads in obesity drugs with Mounjaro and Zepbound, both based on tirzepatide, a GLP-1 drug that targets hormonal digestion pathways.
Summaries by ByteBrief